Efficacy of reduced dose of intravitreal triamcinolone acetonide in a case of active serpiginous choroiditis.

Abstract	Active serpiginous choroiditis (SC) is a vision-threatening condition which requires intensive treatment using corticosteroids and/or immunosuppressives, especially if the lesions are involving or encroaching on the macula. Use of oral and intravenous high-dose steroids are contraindicated in uncontrolled diabetics. Intravitreal steroid delivers a localized dose in such situations. This case report highlights the efficacy of reduced dose of intravitreal triamcinolone acetonide (2 mg) in the treatment of active SC.
Authors	Avirupa Ghose, Promod S Bhende, Jyotirmoy Biswas
Journal	Indian journal of ophthalmology (Indian J Ophthalmol) Vol. 64 Issue 9 Pg. 681-682 (Sep 2016) ISSN: 1998-3689 [Electronic] India
PMID	27853021 (Publication Type: Case Reports, Journal Article)
Chemical References	Glucocorticoids Immunosuppressive Agents Triamcinolone Acetonide Azathioprine
Topics	Azathioprine (therapeutic use) Choroiditis (diagnosis, drug therapy) Drug Therapy, Combination Fluorescein Angiography Glucocorticoids (administration & dosage) Humans Immunosuppressive Agents (therapeutic use) Intraocular Pressure Intravitreal Injections Male Middle Aged Treatment Outcome Triamcinolone Acetonide (administration & dosage) Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!